IP Library Assignment 039185/0447
Patent Assignment
Reel/Frame 039185/0447

Assignment of Assignor's Interest

Recorded: 2016-06-28 Pages: 36
Assignors
CHATTERTON, JON E.
Executed: 2008-05-22
CLARK, ABBOT F.
Executed: 2008-05-21
BINGAMAN, DAVID P.
Executed: 2008-05-22
WAX, MARTIN B.
Executed: 2008-05-29
TIMMERS, ADRIAN M.
Executed: 2008-05-22
Assignee
ARROWHEAD PHARMACEUTICALS, INC.
225 SOUTH LAKE AVENUE, SUITE 1050, PASADENA, CALIFORNIA, 91101
Covered Property (1)
RNAi-Related Inhibition of TNF-alpha Signaling Pathway for Treatment of Ocular Angiogenesis
Patent: 9,422,556 →
Application: 14/827,418 →
Publication: US US20150344886A1
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest Aug 7, 2024
From: ARROWHEAD PHARMACEUTICALS, INC.
To: SIXTH STREETLENDING PARTNERS, AS THE ADMINISTRATIVE AGENT
Reel/Frame 068510/0363 →